170 related articles for article (PubMed ID: 4625803)
1. A controlled study of haloprogin and tolnaftate in tinea pedis.
Carter VH
Curr Ther Res Clin Exp; 1972 Jun; 14(6):307-10. PubMed ID: 4625803
[No Abstract] [Full Text] [Related]
2. Haloprogin therapy for dermatophyte infections.
Katz R; Cahn B
Arch Dermatol; 1972 Dec; 106(6):837-8. PubMed ID: 4565228
[No Abstract] [Full Text] [Related]
3. Clinical efficacy studies of haloprogin, a new topical antimicrobial agent.
Hermann HW
Arch Dermatol; 1972 Dec; 106(6):839-42. PubMed ID: 4565229
[No Abstract] [Full Text] [Related]
4. Clinical evaluation of haloprogin.
Hermann HW
Toxicol Appl Pharmacol; 1972 Dec; 23(4):598-605. PubMed ID: 4264777
[No Abstract] [Full Text] [Related]
5. Comparison between undecylenic acid and tolnaftate in the treatment of tinea pedis.
Fuerst JF; Cox GF; Weaver SM; Duncan WC
Cutis; 1980 May; 25(5):544-6, 549. PubMed ID: 6991217
[TBL] [Abstract][Full Text] [Related]
6. Haloprogin for tinea.
Med Lett Drugs Ther; 1973 Aug; 15(17):69-70. PubMed ID: 4740517
[No Abstract] [Full Text] [Related]
7. Prophylaxis of tinea pedis. Efficacy of tolnaftate powder and its talc-cornstarch base.
Burrill BB; Nemlick AS
J Med Soc N J; 1970 Oct; 67(10):629-31. PubMed ID: 4920842
[No Abstract] [Full Text] [Related]
8. Drugs for athlete's foot and tinea cruris.
Med Lett Drugs Ther; 1976 Nov; 18(24):101-2. PubMed ID: 1036605
[No Abstract] [Full Text] [Related]
9. Treatment of long-term tinea pedis with miconazole. Double-blind clinical evaluation.
Brugmans JP; Van Cutsem JM; Thienpont DC
Arch Dermatol; 1970 Oct; 102(4):428-32. PubMed ID: 4919243
[No Abstract] [Full Text] [Related]
10. [Therapeutic efficacy of a topical tolnaftate preparation in guinea pig model of tinea pedis].
Yamaguchi H; Uchida K; Tanaka T; Yamaguchi T
Jpn J Antibiot; 2001 Jun; 54(6):323-30. PubMed ID: 11521512
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effectiveness of griseofulvin, tolnaftate, and placebo in the topical therapy of superficial dermatophytoses.
Zarowny DP; Rogers RS; Tindall JP
J Invest Dermatol; 1975 Apr; 64(4):268-72. PubMed ID: 1090684
[No Abstract] [Full Text] [Related]
12. [Report on clinical experience with antimycotic VUFB 9244 (Jopargin)].
Klíma J
Cesk Dermatol; 1976 Jun; 51(3):168-73. PubMed ID: 782732
[No Abstract] [Full Text] [Related]
13. Comparison of over-the-counter agents for tinea pedis.
Tschen EH; Becker LE; Ulrich JA; Hoge WH; Smith EB
Cutis; 1979 May; 23(5):696-8. PubMed ID: 378561
[TBL] [Abstract][Full Text] [Related]
14. New topical agents for dermatophytosis.
Smith EB
Cutis; 1976 Jan; 17(1):54-8. PubMed ID: 1037098
[TBL] [Abstract][Full Text] [Related]
15. [Report on clinical experience with antimycotic VUFB 9244 (Jopargin) (author's transl)].
Klima J
Cesk Dermatol; 1976 Jun; 51(3):168-73. PubMed ID: 782733
[No Abstract] [Full Text] [Related]
16. Use of tolnaftate powder in the treatment and prophylaxis of foot mycoses.
Balogh E; Nagy E; Mészáros C
Ther Hung; 1988; 36(2):86-7. PubMed ID: 3201392
[No Abstract] [Full Text] [Related]
17. Experimental ringworm infection in guineapig for the evaluation of drugs.
Srivastava OP; Chandra B; Mathur IS; Gupta HP
Indian J Exp Biol; 1978 Jun; 16(6):700-1. PubMed ID: 700801
[No Abstract] [Full Text] [Related]
18. Miconazole treatment for severe dermatophytoses.
Mandy SJ; Garrott TC
JAMA; 1974 Oct; 230(1):72-5. PubMed ID: 4606810
[No Abstract] [Full Text] [Related]
19. Tolnaftate in the treatment of superficial mycotic infections.
Vibhatavanija T; Phanich V; Thianprasit M; Youngchaiyud U
Southeast Asian J Trop Med Public Health; 1972 Jun; 3(2):277-9. PubMed ID: 4563192
[No Abstract] [Full Text] [Related]
20. Tolnaftate (tinactin), a new topical antifungal agent.
Adam JE; Craig GE
Can Med Assoc J; 1965 Nov; 93(19):1004-5. PubMed ID: 5319027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
